Organon & Co. (BMV:OGN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Women's Health Revenue	1.82B	1.78B	1.70B
Women's Health Revenue Growth	2.42%	4.41%	1.73%
Biosimilars Revenue	673.00M	662.00M	593.00M
Biosimilars Revenue Growth	1.66%	11.64%	23.29%
Established Brands Revenue	3.71B	3.85B	3.85B
Established Brands Revenue Growth	-3.51%	0.05%	-0.70%
Other Product Group Revenue	94.00M	115.00M	121.00M
Other Product Group Revenue Growth	-18.26%	-4.96%	-17.12%
Revenue (Total)	6.30B	6.40B	6.26B
Revenue (Total) Growth	-1.59%	2.23%	1.44%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
United States Revenue	1.65B	1.57B	1.48B
United States Revenue Growth	4.83%	6.36%	2.85%
Europe and Canada Revenue	1.63B	1.76B	1.67B
Europe and Canada Revenue Growth	-7.43%	5.38%	2.57%
Asia Pacific and Japan Revenue	996.00M	1.05B	1.13B
Asia Pacific and Japan Revenue Growth	-5.14%	-7.00%	-1.23%
China Revenue	840.00M	847.00M	864.00M
China Revenue Growth	-0.83%	-1.97%	-5.78%
Latin America, Middle East, Russia and Africa Revenue	1.08B	1.03B	965.00M
Latin America, Middle East, Russia and Africa Revenue Growth	4.16%	7.15%	7.82%
Other International Revenue	108.00M	137.00M	154.00M
Other International Revenue Growth	-21.17%	-11.04%	1.99%
International Revenue	4.65B	4.83B	4.79B
International Revenue Growth	-3.69%	0.96%	1.01%
Revenue (Total)	6.30B	6.40B	6.26B
Revenue (Total) Growth	-1.59%	2.23%	1.44%

Updated Sep 30, 2025. Data Source: Fiscal.ai.